The Lancet. Oncology
Misclassification of p16-positive, HPV-negative patients biases de-escalation trials - Authors' reply.
David M Routman, James S Lewis, Daniel J Ma
Published: 202510.1016/S1470-2045(25)00655-2
No abstract available for this study.